tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ARMP Stock Latest News

Armata Pharmaceuticals Reports Positive Phase 2 Study Results
Company AnnouncementsArmata Pharmaceuticals Reports Positive Phase 2 Study Results
1M ago
8K
ARMP
Armata Pharma’s inhaled AP-PA02 shows positive results in Phase 2 study
PremiumThe Fly
Armata Pharma’s inhaled AP-PA02 shows positive results in Phase 2 study
1M ago
ARMP
Armata Pharmaceuticals Announces CMO Departure Agreement
PremiumCompany Announcements
Armata Pharmaceuticals Announces CMO Departure Agreement
2M ago
8K
ARMP
Armata Pharmaceuticals Extends Credit Agreement and CMO Departs
PremiumCompany Announcements
Armata Pharmaceuticals Extends Credit Agreement and CMO Departs
2M ago
8K
ARMP
Armata Pharmaceuticals reports Q3 EPS (15c) vs. (86c) last year
PremiumThe Fly
Armata Pharmaceuticals reports Q3 EPS (15c) vs. (86c) last year
2M ago
ARMP
Armata Completes Enrollment for Innovative Bacteriophage Study
PremiumCompany AnnouncementsArmata Completes Enrollment for Innovative Bacteriophage Study
2M ago
8K
ARMP
Armata Pharmaceuticals completes enrollment of Phase 1b/2a diSArm study
Premium
The Fly
Armata Pharmaceuticals completes enrollment of Phase 1b/2a diSArm study
2M ago
ARMP
ARMP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ARMP Earnings this Week: How Will it Perform?
2M ago
ARMP
Armata Pharmaceuticals VP Richard Rychlik Departs with Benefits
PremiumCompany Announcements
Armata Pharmaceuticals VP Richard Rychlik Departs with Benefits
4M ago
8K
ARMP
Armata Pharmaceuticals Updates Progress and Corporate Presentation
PremiumCompany Announcements
Armata Pharmaceuticals Updates Progress and Corporate Presentation
5M ago
8K
ARMP
Armata Pharmaceuticals Welcomes David House as New SVP of Finance
PremiumCompany Announcements
Armata Pharmaceuticals Welcomes David House as New SVP of Finance
5M ago
8K
ARMP
Armata Pharmaceuticals reports Q2 EPS (25c) vs. (17c) last year
PremiumThe Fly
Armata Pharmaceuticals reports Q2 EPS (25c) vs. (17c) last year
5M ago
ARMP
ARMP Earnings this Week: How Will it Perform?
PremiumPre-EarningsARMP Earnings this Week: How Will it Perform?
5M ago
ARMP
Armata Pharmaceuticals receives $5.25M of funding from DoD
Premium
The Fly
Armata Pharmaceuticals receives $5.25M of funding from DoD
6M ago
ARMP
Innoviva’s (INVA) Stock Is Thriving With Strategic Investments Pay-Off
Premium
Market News
Innoviva’s (INVA) Stock Is Thriving With Strategic Investments Pay-Off
6M ago
GSK
ARMP
Armata Pharmaceuticals Updates Chief Medical Officer’s Compensation
PremiumCompany Announcements
Armata Pharmaceuticals Updates Chief Medical Officer’s Compensation
6M ago
8K
ARMP
Armata Pharmaceuticals completes enrollment of Phase 2 study of AP-PA02
PremiumThe Fly
Armata Pharmaceuticals completes enrollment of Phase 2 study of AP-PA02
6M ago
ARMP
Armata Pharmaceuticals Under Pressure: Navigating the Risks as Cost-Cutting Measures Threaten Revenue
PremiumCompany Announcements
Armata Pharmaceuticals Under Pressure: Navigating the Risks as Cost-Cutting Measures Threaten Revenue
10M ago
ARMP
Armata Pharmaceuticals reports Q4 EPS (55c) vs. (29c) last year
PremiumThe Fly
Armata Pharmaceuticals reports Q4 EPS (55c) vs. (29c) last year
10M ago
ARMP
ARMP Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsARMP Upcoming Earnings Report: What to Expect?
10M ago
ARMP
Armata Pharmaceuticals reports Q3 EPS (86c) vs. (24c) last year
Premium
The Fly
Armata Pharmaceuticals reports Q3 EPS (86c) vs. (24c) last year
1y ago
ARMP
Is ARMP a Buy, Before Earnings?
Premium
Pre-Earnings
Is ARMP a Buy, Before Earnings?
1y ago
ARMP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >